Skip to main content
. 2022 Apr 5;33(4):572–580. doi: 10.1097/EDE.0000000000001490

TABLE 2.

Baseline Clinical Characteristics in NHANES 1999–2004 With Mortality Followed Through 2015

Variable Total Participants Who Reported Chronic Pain Participants Who Did Not Report Chronic Pain
N 13884 2168 11716
Age, mean (sd) 50.9 (19.6) 53.3 (17.7) 50.4 (20.0)
Male, N (%) 6579 (47) 922 (43) 5657 (48)
Race/ethnicity, N (%)
 Non-Hispanic White 6951 (50) 1274 (59) 5677 (48)
 Non-Hispanic Black 2654 (19) 393 (18) 2261 (19)
 Mexican American 3112 (22) 333 (15) 2779 (24)
 Other Race 1167 (8) 168 (8) 999 (9)
Education years, N (%)
 <9th grade 2287 (17) 316 (15) 1971 (17)
 9–11 grade 2356 (17) 401 (19) 1955 (17)
 High school graduate 3296 (24) 561 (26) 2735 (23)
 College degree or above 5889 (43) 882 (41) 5007 (43)
Poverty income ratio, mean (sd) 2.6 (1.6) 2.4 (1.6) 2.6 (1.6)
Health insurance coverage, N (%) 11038 (81) 1774 (83) 9264 (80)
Marital status (married), N (%) 7425 (56) 1142 (54) 6283 (56)
Smoking, N (%) 6655 (48) 1270 (59) 5385 (46)
Alcohol, N (%) 7937 (57) 1303 (60) 6634 (57)
Anti-depressant medication prescription, N (%) 1038 (7) 372 (17) 666 (6)
Illicit drug usea, N (%) 1419 (16) 299 (23) 1120 (15)
Comorbidities, N (%)
 Coronary heart diseases 639 (5) 184 (9) 455 (4)
 Cancer 1247 (9) 283 (13) 964 (8)
 Arthritis 2375 (17) 735 (34) 1640 (14)
Opioid prescriptions, N(%)
 Total opioidsb 683 (5) 382 (18) 301 (3)
 Opioids equivalent to or stronger than morphinec 360 (3) 223 (10) 137 (1)
a

Illicit drug use was only asked for participants aged 20–59 years (N = 8630).

b

Total opioids included codeine, dihydrocodeine, meperidine, pentazocine, propoxyphene, tramadol, hydrocodone, morphine, tapentadol, fentanyl, hydromorphone, methadone, oxycodone, and oxymorphone.

c

Opioids equivalent to or stronger than morphine included hydrocodone, morphine, tapentadol, fentanyl, hydromorphone, methadone, oxycodone, and oxymorphone.